CAJ | 학술논문

高血压是世界上最广泛的疾病之一,在我国高血压的发病人数逐年增加.高血压是一种多因素疾病,一种不断进展的疾病,进展程度不仅与性别、年龄、生活方式有关,而且与合理治疗有密切的关系,所以如何有效地控制血压成为临床医师研究的重要内容.厄贝沙坦是重要的心血管活性药物,因其临床疗效确切,副作用少而得到广大医务工作者和患者的喜爱.本文选择我院高血压患者32例,采用厄贝沙坦治疗,观察其临床疗效及不良反应发生情况,现报告如下.
고혈압시세계상최엄범적질병지일,재아국고혈압적발병인수축년증가.고혈압시일충다인소질병,일충불단진전적질병,진전정도불부여성별、년령、생활방식유관,이차여합리치료유밀절적관계,소이여하유효지공제혈압성위림상의사연구적중요내용.액패사탄시중요적심혈관활성약물,인기림상료효학절,부작용소이득도엄대의무공작자화환자적희애.본문선택아원고혈압환자32례,채용액패사탄치료,관찰기림상료효급불량반응발생정황,현보고여하.
Hypertension is one of the world's most extensive disease, incidence of hypertension in our country every year. Hypertension is a multifactorial disease, a disease progresses, the degree of progress not only with gender, age, lifestyle, and has a close relationship with the proper treatment, so how to effectively control blood pressure has become an important part of the study clinicians . Irbesartan is important cardiovascular active drugs, because of its clinical efficacy, fewer side effects and the broad masses of medical workers and patients alike. In this paper, our hospital 32 cases of patients with hypertension, the use of irbesartan treatment, clinical efficacy and adverse events, are as follows.